Company Overview
| Stock Name | 金天醫藥集團股份有限公司 |
|---|---|
| Stock Code | 02211 |
| Company Full Name | 金天醫藥集團股份有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國從事分銷及零售藥物及其他醫藥產品。 |
| Listing Date | 2013-12-12 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國遼寧省沈陽市鐵西區北一中路1號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.uhighl.com |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 2.91 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 145,500,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 2.37 |
|---|---|
| First Day Open | HK$ 1.99 |
| First Day Change | -18.56% |
| First Day Volume | 208939000.0 |
| First Day Turnover | 515674000.0 |
Use of Proceeds
| Use of Proceeds | (1) 所得款項凈額約40%將用作為我們于中國（尤其中國東北地區）收購擴張提供資金。截至最后實際可行日期，我們并無物色到任何收購對象； (2) 所得款項凈額約30%將用作為我們的內生增長提供資金，內生增長包括新設藥店以及升級我們現有的物流中心及額外設立物流中心； (3) 所得款項凈額約20%將用作推廣金天愛心、授權品牌及授權品牌產品。根據本集團所 采用的價值鏈整合模式，授權品牌產品相關的推廣和營銷工作通常由分銷商（而非制造商）進行，因為分銷商能夠直接接觸下游客戶。 (4) 所得款項凈額約10%將用作營運資金。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
摩根士丹利亚洲有限公司 CE AAD291
Overall Coordinators (1)
摩根士丹利亚洲有限公司 CE AAD291
Joint Bookrunners (3)
摩根士丹利亚洲有限公司 CE AAD291
星展亚洲融资有限公司 CE AAE430
交银国际证券有限公司 CE APJ121
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 初川富 |
|---|---|
| Company Secretary | 許潔瑩 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 李豐麟(5.23%) |
|---|
